Updated: January 4, 2026
Drospirenone/Ethinyl Estradiol Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Is drospirenone/ethinyl estradiol (Yaz, Yasmin) in a shortage in 2026? Here's the current status and what patients should know about availability.
Patients and healthcare providers tracking drospirenone/ethinyl estradiol availability in 2026 have good news: as of this writing, there is no active FDA-designated national drug shortage for this medication. Generic versions are manufactured by multiple companies, and the drug is broadly available through the national supply chain.
However, individual patients continue to encounter stock-outs at specific pharmacies — sometimes due to formulary changes, manufacturer switches, or local supply chain disruptions. This guide explains the current status and what to do if you're having trouble filling your prescription.
Current Shortage Status: No Active National Shortage (2026)
The FDA maintains an official Drug Shortages Database at fda.gov. As of 2026, drospirenone/ethinyl estradiol is not listed. The drug has multiple approved manufacturers — including generic producers like Bayer (original brand), Teva, Lupin, Glenmark, and others — providing supply redundancy.
This is meaningfully different from drugs like GLP-1 medications (semaglutide, tirzepatide) or ADHD medications that experienced documented national shortages. Drospirenone/ethinyl estradiol has not faced a nationwide supply crisis.
Why Do Patients Still Report Trouble Finding It?
Even when a drug isn't in a national shortage, patients may still encounter local difficulties:
Brand fragmentation: With over 12 branded generics (Loryna, Ocella, Syeda, Nikki, Gianvi, Zarah, Vestura, etc.), patients sometimes encounter a pharmacy that stocks one brand but not theirs.
Formulation differences: The 3mg/0.02mg (Yaz-type) and 3mg/0.03mg (Yasmin-type) formulations are stocked independently. A pharmacy may have one but not the other.
Insurance plan changes: If your insurance plan changed at the start of the year, your preferred generic may no longer be on formulary — or your pharmacy may not stock the new preferred generic.
Manufacturer transitions: Occasionally, a pharmacy will switch its preferred supplier mid-year, causing a temporary gap while new inventory arrives.
Historical Context: Has There Been a Shortage Before?
Drospirenone/ethinyl estradiol has not historically experienced the kind of documented, FDA-tracked shortage seen with some other medications. The broader oral contraceptive category has generally maintained stable supply, in part because multiple manufacturers produce the same active ingredient.
The broader contraceptive supply landscape has faced some disruptions — for instance, some progesterone-only and specialty formulations have had localized shortages — but drospirenone/ethinyl estradiol specifically has remained relatively available.
What Patients Should Do Right Now
Even without a national shortage, proactive steps help ensure uninterrupted access:
Ask for a 90-day supply. A 3-month supply reduces how often you deal with refill logistics.
Know your equivalent generics. If Loryna is unavailable, Gianvi, Nikki, or Vestura may be in stock at the same pharmacy.
Use medfinder to check nearby pharmacies. medfinder calls pharmacies near you to find which ones can fill your prescription so you don't have to call around yourself.
Consider mail-order pharmacy. Many telehealth services and insurance mail-order programs can ship a 90-day supply directly to your home.
How to Monitor Shortage Status Yourself
If you want to stay informed:
Bookmark the FDA Drug Shortage Database and search for "drospirenone" periodically
Ask your pharmacist directly — they often have visibility into supply chain issues 1-2 weeks before patients notice problems
Check patient community forums (Reddit's r/birthcontrol and r/PMDD are particularly active) for real-time patient reports
Bottom Line for Patients in 2026
Drospirenone/ethinyl estradiol is not in a national shortage. The drug is broadly available in generic form from multiple manufacturers at pharmacies nationwide. Individual stock-outs at specific locations do happen, but these are solvable — usually by checking a different pharmacy, requesting an equivalent generic, or using a mail-order service.
For step-by-step help finding your medication: How to Find Drospirenone/Ethinyl Estradiol In Stock Near You.
And if you need to explore alternatives: Alternatives to Drospirenone/Ethinyl Estradiol If You Can't Fill Your Prescription.
Frequently Asked Questions
No. As of 2026, drospirenone/ethinyl estradiol does not have an active FDA-designated national drug shortage. Generic versions are made by multiple manufacturers and are broadly available. You can verify current status at the FDA Drug Shortage Database at fda.gov.
Individual pharmacy stock-outs can occur even without a national shortage. Your pharmacy may stock a different generic brand or formulation, may be between orders, or your insurance formulary may have changed. Try a different nearby pharmacy or ask if an equivalent generic (such as Loryna, Gianvi, Syeda, or Ocella) is in stock.
Drospirenone/ethinyl estradiol has not experienced the kind of FDA-tracked national shortage seen with medications like GLP-1 drugs or stimulants. The drug has maintained relatively stable availability due to having multiple approved manufacturers for its generic forms.
Visit the FDA Drug Shortage Database at accessdata.fda.gov/scripts/drugshortages/ and search for "drospirenone." The database is updated regularly by the FDA and shows active, resolved, and discontinued shortages.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Drospirenone/Ethinyl Estradiol also looked for:
More about Drospirenone/Ethinyl Estradiol
31,889 have already found their meds with Medfinder.
Start your search today.





